Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | CES1 | P23141 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CRHBP | P24387 | 1/20 | 0.45 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.45 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.45 |
| ▸ | PPIA | P62937 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3367391 | 0.83 | MAPT (0.56) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL14924314 | 0.79 | TSHR (0.60) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL171914 | 0.78 | TSHR (0.72) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL7190826 | 0.78 | TSHR (0.64) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL29613904 | 0.78 | TSHR (0.72) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL1970698 | 0.78 | CASP6 (0.39) | TSHRALDH1A1CYP3A4HSD17B10TDP1 | |
| SCHEMBL23293742 | 0.77 | TSHR (0.62) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL17117159 | 0.77 | TSHR (0.62) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL15022780 | 0.77 | TSHR (0.47) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL48806 | 0.77 | ALDH1A1 (0.69) | TSHRALDH1A1CYP3A4RECQLHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0591060-B1 | 4-Substituted meta amino phenols, process for their preparation their use in dyeing keratinic fibres and intermediates used in their preparation | OREAL (FR) | 1996-12-18 | — | — | EP | claimed |
| CN-116438214-A | Sealing material for organic EL display element, cured product thereof, and organic EL display device | 三井化学株式会社 | 2023-07-14 | — | — | CN | disclosed |
| WO-2022107692-A1 | SEALING MATERIAL FOR ORGANIC EL DISPLAY ELEMENT, CURED PRODUCT OF SAID SEALING MATERIAL, AND ORGANIC EL DISPLAY DEVICE | 三井化学株式会社 | 2022-05-27 | — | — | WO | disclosed |
| US-20160024098-A1 | HYBRID NECROPTOSIS INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-28 | — | — | US | disclosed |
| CN-1995014-A | Method for preparing 2-nitro-4-methyl p-tolyl sulfone using solid superstrong acid | UNIV HEILONGJIANG (CN) | 2007-07-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024098-A1 | HYBRID NECROPTOSIS INHIBITORS | RIPK3, RIPK1, RIPK4 | TSHR 4186/4885ALDH1A1 4684/4885CYP3A4 4206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.